Overview

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Treatments:
Bevacizumab